Stock & Company Details
Aurinia Pharmaceuticals Inc $AUPH
Price:
N/A
N/A
133M
$2.3B
52 Week High:
N/A
10 Day Average Volume:
N/A
7.51
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
AUPH technical indicators
Latest Aurinia Pharmaceuticals Inc (AUPH) indicator readings as of 2026-10-29.
AUPH's 14-day RSI is 59.7, in neutral territory. At $17.21 it is trading 10.0% above its 200-day moving average of $15.64, and above its 50-day average of $16.50. Price sits near the upper Bollinger Band ($15.60 to $17.61). ADX reads 26.7, indicating a trending market.
Overview
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.
Finance Bot
Ask your questions
Start by typing a question below.
